
Pregnancy in America tends to be safe. However there are other risk and expectant mother faces. The child may be born with Down’s syndrome or another chromosomal abnormality as well as congenital heart problems. In such cases a test has been administered to determine if the fetus is at risk for these conditions. It’s called the nuchal translucency test (NT), in use in America since 1995 at larger medical facilities.
The test is a prenatal test that scans the nuchal fold of the fetus. Using ultrasound the clear space at the back of the baby’s neck is measured. Babies with abnormalities tend to have more fluid at the back of the neck making this area larger than normal during the first trimester. The NT should be conducted when the mother is 11-12 weeks pregnant. It should actually be done at the latest by 13 weeks and 6 days of pregnancy.
The NT is a screening test. It doesn’t give an actual diagnosis. It simply determines the risk of the baby having certain problems. It gives the parents a chance to make decisions about the pregnancy early on. After the NT scan, the parents may decide to have amniocentesis or chorionic villus sampling to find out if the baby really does have these problems.
If amniocentesis is needed because the NT suggested there might be an abnormality there are risks that the parents must consider before taking the test. Miscarriage is less than 1% risk, but it is still a risk. The mother could experience bleeding, leaking fluid or cramping. She could also develop an infection from the procedure. The fetus is rarely harmed by the needle that extracts the amniotic fluid, but it has happened. The mother’s blood could be mixed with the baby’s blood which could be a problem if they have different blood types. The last risk is an inconclusive test that requires a repeat test.
Amniocentesis is the insertion of a needle to remove a small amount of amniotic fluid from the womb or uterus. Testing the amniotic fluid can detect problems with the baby’s genes. It can also reveal the baby’s developmental progress. Amniocentesis is the last test needed after the NT returns questionable results. This result if returned within the first trimester gives the parents options to continue the pregnancy or to terminate it.

The NT is done by the sonographer first measuring the baby to determine if he or she is the right size for their gestational age. The baby is measured from rump to crown. The next step is to use the transducer to find the baby’s nuchal fold and measure its thickness with calipers. The established measurement for a baby at that gestational age is compared to the measurement obtained from the ultrasound. Other factors are also considered for the first trimester screening of a NT. A blood test, the baby’s gestational age and the mother’s age are also factored into the final result. The older the mother, the more likely a chromosomal abnormality might occur. A woman age 40 or older has a much higher risk of chromosomal abnormalities in their babies. There is a 1 in 82 chance of problems in an older woman’s child.
The NT test gives the parent’s some assurance that they don’t need to take an amniocentesis test and that their baby should be normal and healthy. It is the first and safest way to determine if there is a risk of a chromosomal problem or other disorder. It is non-invasive and thus much safer for the mother and child.







